Ernexa Therapeutics (ERNA) Current Taxes (2016 - 2025)
Historic Current Taxes for Ernexa Therapeutics (ERNA) over the last 14 years, with Q3 2025 value amounting to $17000.0.
- Ernexa Therapeutics' Current Taxes fell 555.56% to $17000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $17000.0, marking a year-over-year decrease of 555.56%. This contributed to the annual value of $3000.0 for FY2024, which is 5000.0% up from last year.
- As of Q3 2025, Ernexa Therapeutics' Current Taxes stood at $17000.0, which was down 555.56% from $11000.0 recorded in Q2 2025.
- In the past 5 years, Ernexa Therapeutics' Current Taxes ranged from a high of $18000.0 in Q3 2024 and a low of $2000.0 during Q3 2023
- Moreover, its 3-year median value for Current Taxes was $7000.0 (2023), whereas its average is $8363.6.
- Over the last 5 years, Ernexa Therapeutics' Current Taxes had its largest YoY gain of 80000.0% in 2024, and its largest YoY loss of 1428.57% in 2024.
- Ernexa Therapeutics' Current Taxes (Quarter) stood at $2000.0 in 2023, then skyrocketed by 50.0% to $3000.0 in 2024, then surged by 466.67% to $17000.0 in 2025.
- Its Current Taxes stands at $17000.0 for Q3 2025, versus $11000.0 for Q2 2025 and $11000.0 for Q1 2025.